Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Market Spotlight: Hidradenitis Suppurativa” report has been added to ResearchAndMarkets.com’s offering. This Market Spotlight report covers the Hidradenitis…
DUBLIN–(BUSINESS WIRE)–The “Market Spotlight: Opioid-Induced Constipation” report has been added to ResearchAndMarkets.com’s offering. This Market Spotlight report covers the Opioid-Induced…
SAN DIEGO–(BUSINESS WIRE)–Invivoscribe is pleased to announce that on June 5th the Ministry of Health, Labor and Welfare (MHLW) approved…
LEHI, Utah–(BUSINESS WIRE)–Frelii, Inc. (OTC PINK: FRLI) (“Frelii” or “the Company”) today announced that Ian Jenkins, CEO of Frelii, will…
-Company Also Updates on Additional Revenue-Generating Activity in that Country SAN DIEGO–(BUSINESS WIRE)–Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the “Company”)…
DUBLIN–(BUSINESS WIRE)–The “Market Spotlight: Acne” report has been added to ResearchAndMarkets.com’s offering. This Market Spotlight report covers the Acne market,…
DUBLIN–(BUSINESS WIRE)–The “Global Hyaluronic Acid Market Size, Share & Trends Analysis Report 2019” report has been added to ResearchAndMarkets.com’s offering.…
LYNPARZA is the Only PARP Inhibitor Approved in Japan KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–AstraZeneca and Merck (NYSE: MRK), known as MSD…
AMSTERDAM & BARCELONA, Spain–(BUSINESS WIRE)–SHIONOGI B.V., the European subsidiary of SHIONOGI & Co., Ltd. (Head Office: Osaka, Japan; President &…
BASEL, Switzerland & BOSTON–(BUSINESS WIRE)–Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics company, and Lonza (SWX: LONN),…